Back
Pfizer 10K Form
Sell
23
PFE
Pfizer
Last Price:
26.02
Seasonality Move:
1.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-11-04 | 10Q | PFE/Pfizer Quarterly |
| 2024-08-05 | 10Q | PFE/Pfizer Quarterly |
| 2024-05-08 | 10Q | PFE/Pfizer Quarterly |
| 2024-02-22 | 10K | PFE/Pfizer Annual |
| 2023-11-08 | 10Q | PFE/Pfizer Quarterly |
| 2023-08-09 | 10Q | PFE/Pfizer Quarterly |
Receive PFE News And Ratings
See the #1 stock for the next 7 days that we like better than PFE
PFE Financial Statistics
Sales & Book Value
| Annual Sales: | $58.5B |
|---|---|
| Cash Flow: | $6.06B |
| Price / Cash Flow: | 18.1 |
| Annual Sales: | $16.29 |
| Price / Book: | 1.61 |
Profitability
| EPS (TTM): | 0.74000 |
|---|---|
| Net Income (TTM): | $4.25B |
| Gross Margin: | $33.54B |
| Return on Equity: | 4.63% |
| Return on Assets: | 1.94% |
Pfizer Earnings Forecast
Key Pfizer Financial Ratios
- The Gross Profit Margin over the past 40 years for PFE is 57.34%.
- The Selling, General & Administrative Expenses for PFE have been equal to 25.25% of Gross Profit Margin.
- The Research & Development expenses have been 18.26% of Revenue.
- The Interest Expense is 104.25% of Operating Income.
- The Net Earning history of PFE is 3.62% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 26 years.
Pfizer Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PFE |
| CUSIP: | 717081 |
| Website: | pfizer.com |
Debt
| Debt-to-Equity Ratio: | 0.72 |
|---|---|
| Current Ratio: | 1 |
| Quick Ratio: | 0.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 70.78 |
|---|---|
| Forward P/E Ratio: | 9.02 |